期刊文献+

硝酸酯类药物的临床应用与选用比较 被引量:2

Clinical Application and Comparison of Nitrates
下载PDF
导出
摘要 目的:促进临床合理用药,减少药物不良反应和耐药现象。方法:查阅相关文献资料,对硝酸酯类药物的种类、剂型、机制、药代动力学和药效学等方面进行综述。结果:硝酸酯类药物的结构和剂型不同,药动学有差异,临床用途不同。结论:合理选用不同种类和不同剂型的硝酸酯类药物具有重要的临床意义,临床应予以重视。 Objective. To promote rational use of drugs in clinical application, and decrease the incidence rates of adverse drug reaction and drug resistance. Methods: Refer to relevant literatures. The types, formulations, mechnism, pharmacokinetics and pharmacodynamics of nitrate were reviewed. Results: Due to difference in the structure and formulations of nitrates, there are differences in their pharmacokinetics and clinical use. Conclusions: It is of great importance in reasonable selecting of different types and formulations of nitrates.
出处 《药品评价》 CAS 2011年第4期41-44,共4页 Drug Evaluation
关键词 硝酸酯类 不良反应 耐药 药代动力学 Nitrates Adverse drug reaction Drug resistance Pharmacokinetics
  • 相关文献

参考文献13

  • 1无.1硝酸酯在心血管疾病中规范化应用的专家共识[J].中华心血管病杂志,2010,38(9):770-774. 被引量:52
  • 2Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 Guideline update for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article[J].Journal of the American College of Cardiology,2005,46:1116-1143.
  • 3Gori T,Parker JD.Long-term therapy with organic nitrates[J].Journal of the American College of Cardiology,2004,44:632-634.
  • 4Janota T.Widimsky J.Hypertensive crisis,emergent and urgent hypertensive situations-Current state of knowledge and guidelines for the management[J].Intervencni a Akutni Kardiologie,2010,9(4):198-202.
  • 5唐金陵,王彬译.临床证据[M].北京:北京大学医学出版社,2007.43-54.
  • 6无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2052
  • 7Fox K,Garcia MA,Ardissino D,et al.Guidelines on the management of stable angina pectoris:executive summary:the Task Force on the Management of Stable Angina Pectoris of the European Society of cardiology[J].Europe Heart Journal,2006,27(11):1341-1381.
  • 8Thadani U.,Ripley T.L.Side effects of using nitrates to treat heart failure and the acute coronary syndromes,unstable angina and acute myocardial infarction[J].Expert Opinion on Drug Safety,2007,6(4):385-396.
  • 9任小贺,赵志刚.药源性疾病与合理用药[J].药品评价,2010(8):34-37. 被引量:8
  • 10Wu ZG,Li JN,Fan M,et al.Comparison of the time to onset of action on myocardial ischaemia following intravenous administration of isosorbide dinitrate and 5-isosorbide mononitrate in Chinese patientslJ].Arzneimittelforschung,2004,54(5):275-279.

二级参考文献115

  • 1王凤英.药源性疾病的诊断及其防治[J].湖北中医学院学报,2004,6(3):40-41. 被引量:1
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2052
  • 3王芳.药品说明书引发医患争执的思考[J].中国药师,2007,10(4):402-403. 被引量:19
  • 4国家食品药品监督管理局.关于印发β-内酰胺酶抑制剂抗生素复方制剂技术评价原则的通知[s].国食药监注[2006]44号.
  • 5Gobemado M. Fosfomycin[ J]. Rev Esp Quimioter, 2003,16(1 ) :15- 40.
  • 6Chen J, Jiang XG, Cai L, Pharmacokinetics of three organic nitrates in Chinese healthy male volunteers [ J ]. Arzneimittelforschung, 2004, 54 ( 4 ) : 203-206.
  • 7Wu ZG, Li JN, Fan M,et al. Comparison of the time to onset of action on myocardial ischaemia following intravenous administration of isosorbide dinitrate and 5-isosorbide mononitrate in Chinese patients [ J ]. Arzneimittelforschung,2004,54 ( 5 ) :275-279.
  • 8Sbeit W, Krivoy N, Shiller M, et al. Nimesulide-induced acute hepatitis[ J ]. Ann Pharmacother ,2001,35 (9) : 1049-1052.
  • 9Weiss P, Mouallem M, Bruck R, et al. Nimesulide-induced hepatitis and acute liver failure[ J]. lsr Med Assoc J,1999 ,1 (2) :89-91.
  • 10Rainsford KD. An analysis from clinico-epidemiological data of the principal adverse events from the COX-2 selective NSAID, nimesulide, with particular reference to hepatic injury [ J ]. Inflammopharmacology, 1998,6 ( 3 ) : 203 -221.

共引文献2211

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部